Literature DB >> 2726999

The appetite suppressant, d-fenfluramine, decreases self-stimulation at a feeding site in the lateral hypothalamus.

R C McClelland1, T Sarfaty, L Hernandez, B G Hoebel.   

Abstract

In prior studies rats showed a relative shift from self-stimulation to escape (i.e., from reward to aversion) following a large meal, obesity or anorectic doses of insulin. Racemic fenfluramine, on the other hand, decreased both self-stimulation and escape suggesting it had a general behavior suppressant property. To avoid the depressive, antidopaminergic effects of the l-isomer, this study tested the d-isomer which is primarily serotonergic. Rats were screened for stimulation-induced feeding and then trained to self-stimulate with one lever in 5-min periods that alternated with 5-min periods of automatic stimulation from which the animal could escape with a different lever. d-Fenfluramine (1.5-4.5 mg/kg IP) caused a dose-related decrease in self-stimulation. Stimulation-escape was relatively unaffected. This is interpreted as a decrease in feeding reward due to d-fenfluramine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2726999     DOI: 10.1016/0091-3057(89)90171-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration.

Authors:  Y Wang; N Joharchi; P J Fletcher; E M Sellers; G A Higgins
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

2.  Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine.

Authors:  P J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

3.  Decreased Incentive Motivation Following Knockout or Acute Blockade of the Serotonin Transporter: Role of the 5-HT2C Receptor.

Authors:  Caleb J Browne; Paul J Fletcher
Journal:  Neuropsychopharmacology       Date:  2016-04-29       Impact factor: 7.853

4.  The Combination of Galanin (1-15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression.

Authors:  Noelia Cantero-García; Antonio Flores-Burgess; David Ladrón de Guevara-Miranda; Antonia Serrano; Laura García-Durán; Araceli Puigcerver; Kjell Fuxe; José Ángel Narváez; Luis Javier Santín; Zaida Díaz-Cabiale; Carmelo Millón
Journal:  Biomedicines       Date:  2022-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.